A novel blood test analyzing fragments of cell-free DNA showed robust diagnostic performance for colorectal cancer across clinical subgroups, offering a promising noninvasive screening method.
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
1don MSN
Patients with previously untreatable blood cancer now disease-free after world-first gene therapy
Alyssa Tapley, 16, became the first patient with an aggressive form of leukaemia to have the experimental treatment in 2022.
With a new study in the journal Cell, researchers at Stanford University and Stockholm University have contributed to ...
Scancell reported further positive clinical data for its DNA cancer immunotherapy iSCIB1+, on Tuesday, saying updated phase ...
Groundbreaking research in The Journal of Molecular Diagnostics shows that analysis of specific patterns of cell-free DNA ...
A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 ...
DNA scaffolds that mirror influenza virus protein geometry boost antiviral binding and reduce infection more effectively than free molecules, enabling a modular antiviral design strategy.
A closeup look at colibactin’s structure reveals chemical motifs that guide its mutation-wreaking “warheads” to specific stretches of DNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback